ATE212040T1 - Herstellung von vernetzter amylose als hilfstoff zur kontrollierten freisetzung von wirkstoffen - Google Patents

Herstellung von vernetzter amylose als hilfstoff zur kontrollierten freisetzung von wirkstoffen

Info

Publication number
ATE212040T1
ATE212040T1 AT98902905T AT98902905T ATE212040T1 AT E212040 T1 ATE212040 T1 AT E212040T1 AT 98902905 T AT98902905 T AT 98902905T AT 98902905 T AT98902905 T AT 98902905T AT E212040 T1 ATE212040 T1 AT E212040T1
Authority
AT
Austria
Prior art keywords
cross
linked
high amylose
amylose starch
reaction medium
Prior art date
Application number
AT98902905T
Other languages
English (en)
Inventor
Yves Dumoulin
Francois Carriere
Andre Ingenito
Original Assignee
Labopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labopharm Inc filed Critical Labopharm Inc
Application granted granted Critical
Publication of ATE212040T1 publication Critical patent/ATE212040T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/003—Crosslinking of starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B33/00—Preparation of derivatives of amylose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT98902905T 1997-02-14 1998-02-10 Herstellung von vernetzter amylose als hilfstoff zur kontrollierten freisetzung von wirkstoffen ATE212040T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/800,518 US5807575A (en) 1997-02-14 1997-02-14 Manufacture of cross-linked amylose useful as a excipient for control release of active compounds
PCT/CA1998/000106 WO1998035992A1 (en) 1997-02-14 1998-02-10 Manufacture of cross-linked amylose useful as an excipient for control release of active compounds

Publications (1)

Publication Number Publication Date
ATE212040T1 true ATE212040T1 (de) 2002-02-15

Family

ID=25178603

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98902905T ATE212040T1 (de) 1997-02-14 1998-02-10 Herstellung von vernetzter amylose als hilfstoff zur kontrollierten freisetzung von wirkstoffen

Country Status (12)

Country Link
US (1) US5807575A (de)
EP (1) EP0960131B1 (de)
AT (1) ATE212040T1 (de)
AU (1) AU726272B2 (de)
CA (1) CA2280534C (de)
DE (1) DE69803159T2 (de)
DK (1) DK0960131T3 (de)
ES (1) ES2171008T3 (de)
IL (1) IL131369A (de)
NZ (1) NZ337171A (de)
PT (1) PT960131E (de)
WO (1) WO1998035992A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6248358B1 (en) 1998-08-25 2001-06-19 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets and methods of making and using the same
US6624200B2 (en) 1998-08-25 2003-09-23 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6284273B1 (en) * 1998-02-24 2001-09-04 Vincent Lenaerts Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
GB9924351D0 (en) * 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
WO2002045695A2 (en) 2000-12-05 2002-06-13 Alexander Macgregor Hydrostatic delivery system for controlled delivery of agent
CA2423712A1 (en) 2003-03-26 2004-09-26 Nicolas Nourry Crosslinked amylopectin by reactive extrusion and its use as an absorbent or superabsorbent material
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
JP4463109B2 (ja) * 2002-11-07 2010-05-12 アドバンスド バイオニュートリション コーポレーション 栄養補助食品および水生動物の給餌方法
US6846497B2 (en) * 2003-01-30 2005-01-25 National Starch And Chemical Investment Holding Corporation Rapidly expanding starches with altered crystalline structure
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
WO2006047870A1 (en) 2004-11-02 2006-05-11 Gangagen Life Sciences Inc. Stabilized bacteriophage formulations
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
PT1931346E (pt) * 2005-09-09 2012-08-14 Angelini Labopharm Llc Composição de trazodona para administração uma vez por dia
JP2009507047A (ja) 2005-09-09 2009-02-19 ラボファーム インコーポレイテッド 持続性薬物放出組成物
WO2007105719A1 (ja) * 2006-03-14 2007-09-20 National University Corporation NARA Institute of Science and Technology 新規なヘパリン代替材料およびその製造方法
US8895066B2 (en) * 2007-10-16 2014-11-25 Paladin Labs Inc. Bilayer composition for the sustained release of acetaminophen and tramadol
US8563066B2 (en) 2007-12-17 2013-10-22 New World Pharmaceuticals, Llc Sustained release of nutrients in vivo
PT2234607E (pt) 2007-12-28 2011-09-30 Acraf Formulação de libertação lenta com base numa associação de glicogénio e alginato
MY156288A (en) 2008-07-16 2016-01-29 Richter Gedeon Nyrt Pharmaceutical formulations containing dopamine receptor ligands.
US20100068268A1 (en) * 2008-09-15 2010-03-18 Miloud Rahmouni Starch-based microparticles for the release of agents disposed therein
BRPI1006902A2 (pt) 2009-01-23 2016-02-16 Aziende Chimiche Riunte Angelini Francesco A C R A F S P A formulação farmacêutica ou alimentícia de liberação controlada, processo para a produção de uma forma farmacêutica ou alimentícia, sistema de liberação controlada, e, uso de um sistema de liberação controlada
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
GB2567493B (en) 2017-10-13 2019-12-18 Altus Formulation Inc Starch-based release modifying excipients and pharmaceutical compositions derived therefrom
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3087860A (en) * 1958-12-19 1963-04-30 Abbott Lab Method of prolonging release of drug from a precompressed solid carrier
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4369308A (en) * 1981-07-24 1983-01-18 National Starch And Chemical Corporation Low swelling starches as tablet disintegrants
US4667590A (en) * 1984-12-10 1987-05-26 Mars, Inc. Closed food processing system and liquid adjustment apparatus for use therein
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
FI950301A0 (fi) * 1992-07-24 1995-01-24 Labopharm Inc Silloitettu polyhydroksyylimateriaali entsymaattisesti kontrolloitua lääkkeen vapauttamista varten

Also Published As

Publication number Publication date
DE69803159D1 (de) 2002-02-21
IL131369A0 (en) 2001-01-28
EP0960131A1 (de) 1999-12-01
DK0960131T3 (da) 2002-05-06
PT960131E (pt) 2002-06-28
IL131369A (en) 2002-12-01
EP0960131B1 (de) 2002-01-16
WO1998035992A1 (en) 1998-08-20
US5807575A (en) 1998-09-15
CA2280534A1 (en) 1998-08-20
AU726272B2 (en) 2000-11-02
AU5978598A (en) 1998-09-08
ES2171008T3 (es) 2002-08-16
DE69803159T2 (de) 2002-08-29
NZ337171A (en) 2000-09-29
CA2280534C (en) 2003-08-19

Similar Documents

Publication Publication Date Title
ATE212040T1 (de) Herstellung von vernetzter amylose als hilfstoff zur kontrollierten freisetzung von wirkstoffen
ES2041885T3 (es) Un procedimiento para la fabricacion de un producto gelificado.
BRPI0112140B8 (pt) comprimido de liberação controlada, processo para a fabricação, em um meio aquoso, de um excipiente de liberação controlada e amido reticulado de elevado teor de amilose.
JPH0531000A (ja) 天然又は合成高分子化合物の選択的加水分解及び／又は熱分解方法
PL358378A1 (en) Process for cooking/drying high-amylose starches
MX9706062A (es) FORMAS DE DOSIFICACION ORAL CONTENIENDO UN ANTIBIOTICO DE beta -LACTAMA.
ATE65940T1 (de) Kontinuierliches verfahren zur herstellung von natriumperborat-granulaten.
Kurakake et al. Effects on maize starch properties of heat-treatment with water–ethanol mixtures
WO1999009066B1 (en) Preparation of pregelatinized high amylose starch and debranched starch useful as an excipient for controlled release of active agents
NO976096L (no) FremgangsmÕte for fremstilling av por°se granuler og anlegg for utf°relse av fremgangsmÕten
DK2183283T3 (en) PROCEDURE FOR PREPARING COLD WATER SWALLOWING PHOSPHAT CROSS-GELATINED STARCH
ATE16271T1 (de) Zeolithgranulat, verfahren zu seiner herstellung und verwendung.
ATE154754T1 (de) Verfahren zur herstellung von pvp-h202-produkten
US20020132309A1 (en) Enzamatically modified hydrophobic starch
DE69306818D1 (de) Verfahren zur Herstellung von destrukturierter Stärke
JPH01311101A (ja) でんぷんエーテルの製造方法
MXPA99008569A (es) Polimerizacion de mono y disacaridos utilizando bajos niveles de acidos policarboxilicos.
BR0211841A (pt) Secagem de artigos cerâmicos durante manufatura
EP0261926A3 (de) Wärmeisoliermaterial und Verfahren zu seiner Herstellung
JPS55709A (en) Novel polysaccharide and its use
DE50209196D1 (de) Verfahren zur herstellung von bleichaktivatorgranulaten
JPS6113486B2 (de)
KR100461565B1 (ko) 저점도 히드록시프로필메틸 셀룰로오스의 제조방법
TH20000A (th) แป้งและผงแป้งที่ใด้ยับยั้งแล้งด้วยความร้อน และขบวนการสำหรับการผลิต
TH25111B (th) แป้งและผงแป้งที่ใด้ยับยั้งแล้งด้วยความร้อน และขบวนการสำหรับการผลิต

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee